Eddc (experimental Drug Development Centre), A*star Research Entities

This early-phase study tests a new drug called EBC-129, alone or with another drug (pembrolizumab), in people with advanced solid tumours that have stopped responding to standard treatments. The main goals are to check safety, find the best dose, and see if tumours shrink. About …